219 related articles for article (PubMed ID: 26824013)
1. Translational control of the fibroblast-extracellular matrix association: An application to pulmonary fibrosis.
Nho RS; Polunovsky V
Translation (Austin); 2013; 1(1):e23934. PubMed ID: 26824013
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
[TBL] [Abstract][Full Text] [Related]
4. Fibrotic myofibroblasts manifest genome-wide derangements of translational control.
Larsson O; Diebold D; Fan D; Peterson M; Nho RS; Bitterman PB; Henke CA
PLoS One; 2008 Sep; 3(9):e3220. PubMed ID: 18795102
[TBL] [Abstract][Full Text] [Related]
5. Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis.
Xia H; Diebold D; Nho R; Perlman D; Kleidon J; Kahm J; Avdulov S; Peterson M; Nerva J; Bitterman P; Henke C
J Exp Med; 2008 Jul; 205(7):1659-72. PubMed ID: 18541712
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis.
Mei Q; Liu Z; Zuo H; Yang Z; Qu J
Front Pharmacol; 2021; 12():797292. PubMed ID: 35126134
[TBL] [Abstract][Full Text] [Related]
7. Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway.
Pei X; Zheng F; Li Y; Lin Z; Han X; Feng Y; Tian Z; Ren D; Cao K; Li C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159160
[TBL] [Abstract][Full Text] [Related]
8. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
9. Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis.
Radwanska A; Cottage CT; Piras A; Overed-Sayer C; Sihlbom C; Budida R; Wrench C; Connor J; Monkley S; Hazon P; Schluter H; Thomas MJ; Hogaboam CM; Murray LA
JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35993367
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
[TBL] [Abstract][Full Text] [Related]
11. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
12. Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis.
Herrera J; Beisang DJ; Peterson M; Forster C; Gilbertsen A; Benyumov A; Smith K; Korenczuk CE; Barocas VH; Guenther K; Hite R; Zhang L; Henke CA; Bitterman PB
Am J Respir Crit Care Med; 2018 Aug; 198(4):486-496. PubMed ID: 29579397
[TBL] [Abstract][Full Text] [Related]
13. New therapeutics based on emerging concepts in pulmonary fibrosis.
Sontake V; Gajjala PR; Kasam RK; Madala SK
Expert Opin Ther Targets; 2019 Jan; 23(1):69-81. PubMed ID: 30468628
[TBL] [Abstract][Full Text] [Related]
14. The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype.
Mebratu YA; Soni S; Rosas L; Rojas M; Horowitz JC; Nho R
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C565-C579. PubMed ID: 37486065
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis.
Gajjala PR; Kasam RK; Soundararajan D; Sinner D; Huang SK; Jegga AG; Madala SK
JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34520400
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis Reveals Differential Expression Profiles in Idiopathic Pulmonary Fibrosis Cell Lines.
Velázquez-Enríquez JM; Ramírez-Hernández AA; Navarro LMS; Reyes-Avendaño I; González-García K; Jiménez-Martínez C; Castro-Sánchez L; Sánchez-Chino XM; Vásquez-Garzón VR; Baltiérrez-Hoyos R
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563422
[TBL] [Abstract][Full Text] [Related]
17. Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis.
Gajjala PR; Singh P; Odayar V; Ediga HH; McCormack FX; Madala SK
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769178
[TBL] [Abstract][Full Text] [Related]
18. αvβ3 Integrin drives fibroblast contraction and strain stiffening of soft provisional matrix during progressive fibrosis.
Fiore VF; Wong SS; Tran C; Tan C; Xu W; Sulchek T; White ES; Hagood JS; Barker TH
JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333317
[TBL] [Abstract][Full Text] [Related]
19. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis.
Tian Y; Li H; Gao Y; Liu C; Qiu T; Wu H; Cao M; Zhang Y; Ding H; Chen J; Cai H
Clin Proteomics; 2019; 16():6. PubMed ID: 30774578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
